Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 277

1.

Levodopa-carbidopa intestinal gel for treatment of advanced Parkinson's disease.

Fernandez HH, Odin P.

Curr Med Res Opin. 2011 May;27(5):907-19. doi: 10.1185/03007995.2011.560146. Epub 2011 Feb 25. Review.

PMID:
21351823
2.

Multicenter controlled study of Sinemet CR vs Sinemet (25/100) in advanced Parkinson's disease.

Hutton JT, Morris JL, Bush DF, Smith ME, Liss CL, Reines S.

Neurology. 1989 Nov;39(11 Suppl 2):67-72; discussion 72-3.

PMID:
2685652
3.

Controlled-release carbidopa/levodopa (CR4-Sinemet) in Parkinson's disease patients with and without motor fluctuations.

Goetz CG, Tanner CM, Shannon KM, Carroll VS, Klawans HL, Carvey PM, Gilley D.

Neurology. 1988 Jul;38(7):1143-6.

PMID:
3290706
4.

Controlled release levodopa treatment of motor fluctuations in Parkinson's disease.

Juncos JL, Fabbrini G, Mouradian MM, Serrati C, Kask AM, Chase TN.

J Neurol Neurosurg Psychiatry. 1987 Feb;50(2):194-8.

5.

[Continuous dopaminergic stimulation by Duodopa in advanced Parkinson's disease: Efficacy and safety].

Annic A, Devos D, Seguy D, Dujardin K, Destée A, Defebvre L.

Rev Neurol (Paris). 2009 Aug-Sep;165(8-9):718-27. doi: 10.1016/j.neurol.2008.11.017. Epub 2009 Jan 15. French.

PMID:
19150100
6.

Controlled-release carbidopa/levodopa in the treatment of Parkinsonism.

Hutton JT, Dippel RL, Bianchine JR, Strahlendorf HK, Meyer PG.

Clin Neuropharmacol. 1984;7(2):135-9.

PMID:
6375861
7.

Controlled-release levodopa/carbidopa. III: Sinemet CR5 treatment of response fluctuations in Parkinson's disease.

Cedarbaum JM, Hoey M, Kutt H, McDowell FH.

Clin Neuropharmacol. 1988 Apr;11(2):168-73.

PMID:
3378225
8.

[Advanced course of Parkinson disease. Little improved motion with continuous intestinal levodopa administration].

Oberpichler-Schwenk H.

Med Monatsschr Pharm. 2005 Jul;28(7):245-6. German. No abstract available.

PMID:
16038123
9.

Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease.

Hauser RA, Ellenbogen AL, Metman LV, Hsu A, O'Connell MJ, Modi NB, Yao HM, Kell SH, Gupta SK.

Mov Disord. 2011 Oct;26(12):2246-52. doi: 10.1002/mds.23861. Epub 2011 Jul 13.

PMID:
21755537
10.

Treatment of Parkinson's disease with controlled-release Carbidopa/L-DOPA.

Pahwa R, Koller WC.

Adv Neurol. 1996;69:487-91. No abstract available.

PMID:
8615169
11.

Carbidopa/levodopa pharmacy errors in Parkinson's disease.

Khadem NR, Nirenberg MJ.

Mov Disord. 2010 Dec 15;25(16):2867-71. doi: 10.1002/mds.23311.

PMID:
20818662
12.

[Treatment for advanced Parkinson's disease with intestinal levodopa/carbidopa gel: review of efficacy and safety].

Timofeeva AA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(11):145-51. Review. Russian.

PMID:
25629138
13.

Clinical inquiry. Which drugs work best for early Parkinson's disease?

Jain L, Benko R, Safranek S.

J Fam Pract. 2012 Feb;61(2):106-8. Review.

PMID:
22312616
14.

The nurse's role in clinical trials.

Amyot D, Gray P, Demong C, Wilson W, Murphy D, Watson J, Duff J.

Can Nurse. 1996 Nov;92(10):30-2.

PMID:
9095759
15.

Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.

Nyholm D, Nilsson Remahl AI, Dizdar N, Constantinescu R, Holmberg B, Jansson R, Aquilonius SM, Askmark H.

Neurology. 2005 Jan 25;64(2):216-23.

PMID:
15668416
16.

Treatment of Parkinson's disease.

Lieberman A.

Curr Opin Neurol Neurosurg. 1993 Jun;6(3):339-43. Review.

PMID:
8507903
17.

Supplement: treatment for Parkinson's disease.

Muilenburg ND.

Neurology. 1995 Dec;45(12):2301-2. No abstract available.

PMID:
8848222
18.

Levodopa in Parkinson's disease: from the past to the future.

Pezzoli G, Zini M.

Expert Opin Pharmacother. 2010 Mar;11(4):627-35. doi: 10.1517/14656561003598919. Review.

PMID:
20163273
19.

Sinemet CR in Parkinson's disease.

Pfeiffer RF, Wilken KE, Glaeske CS, Hofman R.

Nebr Med J. 1991 Jan;76(1):8-10.

PMID:
1997878
20.

Supplemental Content

Support Center